Collagen peptide-based medicament compositions and devices and methods of production and use thereof

A method for treating an ocular disease, disorder or wound in a human or veterinary animal suffering from said ocular disease, disorder, or wound comprising administering a composition comprising collagen mimetic peptide (CMP) consisting of the amino acid sequence of SEQ ID NO:

• 6, and one or more pharmaceutically acceptable carriers to an eye of said human or veterinary animal in a dosage sufficient to treat said ocular disease, disorder or wound, monitoring said ocular disease, disorder or wound in said human or veterinary animal over time, and readministering said composition to the eye until said ocular disease, disorder or wound is treated or ameliorated;
• and
• wherein said ocular disease, disorder or wound is the selected from the group consisting of glaucoma, dry eye syndrome, conjunctivitis, corneal keratitis, corneal laceration, corneal erosion, corneal abrasion, cataracts, vitreous adhesions or floaters, non-infectious corneal ulceration, non-infectious corneal melting, infectious corneal ulceration, infectious corneal melting, Stevens-Johnson Syndrome, scleritis, episcleritis, ectasia, keratoconus, and post-operative afflictions of the eye resulting from eye surgery.